The current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons, the US Preventive Services Task Force has concluded.
The current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons, the US Preventive Services Task Force has concluded.